Charles‐Édouard Luyt
Inserm(FR)Inserm(FR)Centre Hospitalier Universitaire de Grenoble(FR)Sorbonne Université(FR)Assistance Publique – Hôpitaux de Paris(FR)Assistance Publique – Hôpitaux de Paris(FR)ClearMotion (United States)(US)Laboratoire National de Référence(MA)Pitié-Salpêtrière Hospital(FR)Chumakov Institute of Poliomyelitis and Viral Encephalitides(RU)Hôpital Charles-Foix(FR)Fondation pour l’innovation en Cadiométabolisme et Nutrition(FR)Fondation pour l’innovation en Cadiométabolisme et Nutrition(FR)Hôpital Tenon(FR)Imation (United States)(US)Université Grenoble Alpes(FR)
Publications by Year
Research Areas
Nosocomial Infections in ICU, Mechanical Circulatory Support Devices, Pneumonia and Respiratory Infections, Cardiac Arrest and Resuscitation, Respiratory Support and Mechanisms
Most-Cited Works
- → Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial(2010)1,167 cited
- → IgA dominates the early neutralizing antibody response to SARS-CoV-2(2020)1,115 cited
- → Ventilator-associated pneumonia in adults: a narrative review(2020)972 cited
- → Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock*(2008)640 cited
- → Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths(2021)617 cited
- → The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome(2013)